DaVitaDVAEarnings & Financial Report
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
DVA Q1 2026 Key Financial Metrics
売上高
$3.6B
粗利益
N/A
営業利益
$561.1M
純利益
$234.2M
粗利益率
N/A
営業利益率
15.5%
純利益率
6.5%
前年比成長
12.3%
EPS
$3.22
資金フロー
DaVita Q1 2026 Financial Summary
DaVita reported revenue of $3.6B for Q1 2026, with a net profit of $234.2M (6.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $3.6B |
|---|---|
| Net Profit | $234.2M |
| Gross Margin | N/A |
| Operating Margin | 15.5% |
| Report Period | Q1 2026 |
DaVita Annual Revenue by Year
DaVita annual revenue history includes year-by-year totals (for example, 2025 revenue was $13.6B).
| Year | Annual Revenue |
|---|---|
| 2025 | $13.6B |
| 2024 | $12.8B |
| 2023 | $12.1B |
| 2022 | $11.6B |
損益計算書
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $3.19B | $3.26B | $3.29B | $3.22B | $3.38B | $3.42B | $3.62B | $3.62B |
| 前年比成長 | 6.2% | 4.6% | 4.7% | 5.0% | 6.1% | 4.8% | 9.9% | 12.3% |
貸借対照表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $17.03B | $17.50B | $17.29B | $17.12B | $17.49B | $17.56B | $17.48B | $17.48B |
| 総負債 | $14.60B | $15.28B | $15.19B | $15.46B | $15.94B | $16.22B | $16.32B | $16.32B |
| 株主資本 | $632.9M | $386.7M | $121.1M | $-267.1M | $-369.6M | $-571.9M | $-651.1M | $-651.1M |
キャッシュフロー
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| 営業CF | $798.8M | $810.4M | $547.6M | $180.0M | $324.2M | $841.5M | $540.7M |
Other Health Care Companies
CI
Cigna
売上高
$69.7B
純利益
N/A
CVS
CVS Health
売上高
$105.7B
純利益
$2.9B
LH
Labcorp
売上高
$3.6B
純利益
$261.1M
DGX
Quest Diagnostics
売上高
$2.8B
純利益
$245.0M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B